FDA Inspection
Teva Canada LimitedTeva Canada Limited – FDA Inspection, Oct 25, 2019
Record Details
This FDA Inspection record concerns Teva Canada Limited, with an inspection on October 25, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Teva Canada Limited
- Inspection Date
- October 25, 2019
- Product Type
- Drugs
View Company Profile
ID · aef8bac3-86c8-412a-a631-33bb71095ab3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1107481
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.166(a)(1)Sample size - test intervals
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Teva Canada Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 10, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 14, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 29, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Canada Limited
- FDA Inspection 1224785 - 2023-11-10
- FDA Inspection 1038516 - 2017-12-14
- FDA Inspection 961307 - 2016-02-05
- FDA Inspection 838128 - 2013-05-24
- FDA Inspection 749939 - 2011-09-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.